Antiplätttertherapie
Antiplättlertherapie, also known as antiplatelet therapy, is a medical treatment aimed at preventing blood clots and reducing the risk of cardiovascular events such as heart attacks and strokes. It is commonly used in patients with conditions that increase the risk of blood clots, such as coronary artery disease, peripheral artery disease, and certain types of cancer.
The primary mechanism of action of antiplatelet therapy is to inhibit the aggregation of platelets, which are
Commonly prescribed antiplatelet drugs include aspirin, clopidogrel, and prasugrel. Aspirin works by inhibiting the enzyme cyclooxygenase,
Antiplättlertherapie is typically initiated after a cardiovascular event, such as a heart attack or stroke, or
While antiplatelet therapy is generally well-tolerated, it can cause side effects such as gastrointestinal bleeding, bruising,